av/bumrungrad-hospital--big.svg

COM:BUMRUNGRAD

Bumrungrad International Hospital

  • Stock

Last Close

206.00

25/11 04:40

Market Cap

193.88B

Beta: -

Volume Today

3.81M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
269.14M
-
298.21M
10.80%
300.48M
0.76%
309.54M
3.02%
308.93M
0.20%
349.82M
13.24%
361.07M
3.21%
319.76M
11.44%
318.38M
0.43%
326.65M
2.60%
344.00M
5.31%
average payables
674.00M
-
723.01M
7.27%
754.09M
4.30%
745.07M
1.20%
745.67M
0.08%
770.86M
3.38%
761.03M
1.28%
635.13M
16.54%
606.64M
4.49%
774.88M
27.73%
896.66M
15.72%
average receivables
1.32B
-
1.42B
7.20%
1.92B
35.71%
2.01B
4.43%
1.76B
12.45%
2.19B
24.62%
2.65B
21.22%
2.48B
6.69%
1.83B
25.98%
2.06B
12.34%
3.53B
71.55%
book value per share
13.17
-
14.94
13.39%
17.48
17.02%
19.86
13.64%
22.51
13.32%
25.32
12.50%
27.40
8.22%
23.71
13.49%
21.75
8.24%
24.79
13.96%
27.07
9.19%
capex per share
-3.06
-
-1.80
41.21%
-2.11
17.43%
-3.37
59.19%
-2.29
32.03%
-1.23
46.42%
-2.59
110.98%
-1.27
50.90%
-1.22
3.95%
-1.54
25.89%
-1.93
25.76%
capex to depreciation
-2.53
-
-1.26
50.35%
-1.47
17.44%
-2.15
46.06%
-1.38
35.81%
-0.76
45.22%
-1.54
103.46%
-0.81
47.20%
-0.82
0.96%
-1.09
33.04%
-1.53
39.76%
capex to operating cash flow
-0.68
-
-0.34
50.52%
-0.39
14.58%
-0.47
22.69%
-0.32
32.93%
-0.19
40.65%
-0.38
103.96%
-0.44
14.08%
-0.27
37.94%
-0.20
27.91%
-0.23
18.77%
capex to revenue
-0.16
-
-0.08
46.04%
-0.09
3.94%
-0.14
56.94%
-0.09
33.62%
-0.05
46.36%
-0.10
109.31%
-0.08
21.31%
-0.08
3.14%
-0.06
24.27%
-0.07
12.42%
cash per share
8.04
-
9.06
12.63%
10.10
11.55%
9.16
9.28%
11.35
23.82%
12.36
8.92%
11.65
5.74%
10.41
10.63%
7.47
28.25%
10.41
39.39%
12.39
18.97%
days of inventory on hand
12.58
-
11.22
10.81%
10.85
3.28%
10.88
0.26%
10.74
1.27%
14.24
32.52%
11.72
17.65%
14.70
25.40%
15.46
5.20%
10.71
30.73%
10.03
6.37%
days payables outstanding
28.59
-
28.98
1.34%
26.48
8.60%
25.82
2.50%
26.37
2.10%
28.56
8.34%
26.12
8.57%
25.41
2.72%
32.05
26.17%
28.64
10.66%
25.54
10.81%
days sales outstanding
33.25
-
35.62
7.11%
47.92
34.53%
34.54
27.91%
36.18
4.74%
51.00
40.96%
54.29
6.44%
65.12
19.96%
42.80
34.28%
46.82
9.41%
63.61
35.85%
debt to assets
0.30
-
0.27
9.79%
0.24
9.89%
0.17
28.62%
0.16
9.06%
0.11
31.16%
0.10
11.36%
0.11
12.18%
0.00
95.80%
0.00
42.35%
0.01
373.97%
debt to equity
0.54
-
0.47
11.72%
0.41
14.34%
0.25
37.10%
0.23
11.65%
0.15
35.52%
0.13
13.36%
0.14
11.86%
0.01
96.12%
0.00
41.18%
0.02
378.98%
dividend yield
0.02
-
0.01
40.82%
0.01
24.36%
0.01
30.10%
0.01
1.71%
0.01
11.07%
0.02
33.93%
0.03
35.09%
0.02
16.25%
0.02
33.57%
0.02
0.67%
earnings yield
0.04
-
0.03
35.86%
0.02
15.91%
0.03
23.03%
0.03
4.15%
0.03
6.39%
0.03
14.81%
0.01
63.30%
0.01
15.48%
0.03
170.08%
0.04
23.60%
enterprise value
60.12B
-
103.20B
71.67%
153.85B
49.07%
130.42B
15.23%
138.94B
6.54%
136.43B
1.81%
107.57B
21.15%
95.18B
11.52%
110.33B
15.92%
166.48B
50.89%
190.07B
14.17%
enterprise value over ebitda
14.58
-
22.41
53.67%
28.30
26.27%
22.84
19.28%
22.60
1.05%
21.36
5.49%
18.23
14.68%
35.07
92.42%
39.21
11.80%
23.21
40.80%
20.40
12.11%
ev to operating cash flow
18.36
-
26.53
44.49%
38.58
45.44%
25.21
34.66%
26.50
5.12%
28.82
8.75%
21.96
23.78%
42.10
91.69%
31.02
26.31%
26.80
13.63%
26.47
1.20%
ev to sales
4.19
-
6.60
57.57%
8.71
31.93%
7.28
16.43%
7.57
4.03%
7.44
1.70%
5.82
21.78%
7.70
32.23%
8.85
15.00%
8.03
9.26%
7.51
6.48%
free cash flow per share
1.43
-
3.54
147.26%
3.36
5.11%
3.73
11.20%
4.91
31.43%
5.27
7.39%
4.13
21.58%
1.62
60.75%
3.26
100.73%
6.28
92.91%
6.35
1.03%
free cash flow yield
0.02
-
0.03
46.43%
0.02
36.59%
0.02
29.63%
0.03
25.87%
0.03
8.54%
0.03
0.24%
0.01
51.92%
0.02
70.83%
0.03
28.30%
0.03
3.95%
graham net net
-0.91
-
0.00
100.43%
1.45
37,228.63%
2.14
47.89%
4.13
92.49%
7.02
70.20%
6.59
6.23%
5.84
11.39%
4.98
14.69%
7.77
56.14%
10.14
30.48%
graham number
32.02
-
35.49
10.82%
43.06
21.35%
47.16
9.52%
52.36
11.01%
56.98
8.82%
56.31
1.17%
28.67
49.09%
27.37
4.54%
58.87
115.12%
70.14
19.15%
income quality
1.04
-
1.14
9.29%
0.94
17.53%
1.18
25.98%
1.10
7.22%
0.94
14.27%
1.08
14.93%
1.65
52.64%
2.44
48.14%
1.03
57.95%
1.02
0.23%
intangibles to total assets
0.01
-
0.01
22.96%
0.01
0.48%
0.02
52.50%
0.03
27.10%
0.03
34.09%
0.03
8.24%
0.03
0.42%
0.04
17.95%
0.03
22.90%
0.00
92.91%
interest coverage
21.91
-
19.14
12.65%
23.55
23.04%
21.24
9.78%
32.97
55.23%
31.53
4.39%
36.84
16.85%
10.76
70.79%
12.69
17.92%
1.69K
13,250.23%
3.43K
102.79%
interest debt per share
7.26
-
7.32
0.82%
7.34
0.24%
5.36
26.98%
5.28
1.56%
3.90
25.99%
3.62
7.22%
3.50
3.38%
0.27
92.30%
0.08
68.80%
0.42
398.52%
inventory turnover
29.01
-
32.53
12.12%
33.64
3.39%
33.55
0.26%
33.98
1.28%
25.64
24.54%
31.14
21.44%
24.83
20.26%
23.60
4.94%
34.07
44.37%
36.39
6.80%
invested capital
0.54
-
0.47
11.72%
0.41
14.34%
0.25
37.10%
0.23
11.65%
0.15
35.52%
0.13
13.36%
0.14
11.86%
0.01
96.12%
0.00
41.18%
0.02
378.98%
market cap
60.83B
-
102.73B
68.88%
153.74B
49.65%
131.88B
14.22%
137.72B
4.43%
136.27B
1.05%
107.14B
21.38%
93.80B
12.45%
112.04B
19.44%
168.51B
50.40%
193.43B
14.79%
net current asset value
-102.73M
-
614.66M
698.33%
1.89B
207.69%
2.26B
19.54%
3.77B
66.82%
6.10B
61.65%
5.82B
4.52%
5.42B
6.95%
4.82B
10.94%
7.17B
48.56%
10.25B
43.06%
net debt to ebitda
-0.17
-
0.10
159.20%
0.02
80.85%
-0.26
1,405.02%
0.20
177.59%
0.02
88.10%
0.07
209.45%
0.51
593.38%
-0.61
219.45%
-0.28
53.41%
-0.36
27.66%
net income per share
3.46
-
3.75
8.30%
4.72
25.84%
4.98
5.54%
5.41
8.76%
5.70
5.27%
5.14
9.74%
1.54
70.04%
1.53
0.68%
6.21
306.08%
8.08
30.01%
operating cash flow per share
4.49
-
5.34
18.80%
5.47
2.49%
7.10
29.75%
7.20
1.34%
6.50
9.72%
6.72
3.44%
2.89
56.96%
4.48
54.76%
7.82
74.65%
8.28
5.89%
payables turnover
12.77
-
12.60
1.32%
13.78
9.41%
14.13
2.56%
13.84
2.06%
12.78
7.70%
13.98
9.38%
14.37
2.80%
11.39
20.74%
12.75
11.93%
14.29
12.13%
receivables turnover
10.98
-
10.25
6.64%
7.62
25.67%
10.57
38.71%
10.09
4.52%
7.16
29.06%
6.72
6.05%
5.61
16.64%
8.53
52.16%
7.80
8.60%
5.74
26.39%
research and ddevelopement to revenue
return on tangible assets
0.15
-
0.14
2.15%
0.16
13.11%
0.17
6.14%
0.17
0.65%
0.17
0.81%
0.15
14.93%
0.05
65.27%
0.06
17.95%
0.21
246.12%
0.24
14.62%
revenue per share
19.69
-
21.45
8.94%
24.24
12.99%
24.59
1.44%
25.18
2.40%
25.15
0.12%
25.35
0.80%
15.82
37.61%
15.68
0.85%
26.07
66.24%
29.16
11.87%
roe
0.26
-
0.25
4.49%
0.27
7.54%
0.25
7.13%
0.24
4.03%
0.22
6.43%
0.19
16.60%
0.06
65.37%
0.07
8.23%
0.25
256.34%
0.30
19.07%
roic
0.18
-
0.18
0.83%
0.20
11.43%
0.21
4.71%
0.20
2.18%
0.20
0.33%
0.17
15.11%
0.06
66.62%
0.07
28.70%
0.25
236.50%
0.28
12.64%
sales general and administrative to revenue
0.18
-
0.18
1.91%
0.18
1.95%
0.17
0.59%
0.17
2.54%
0.16
7.14%
0.18
11.57%
0.25
40.38%
0.24
4.95%
0.15
34.25%
shareholders equity per share
13.17
-
14.94
13.39%
17.48
17.02%
19.86
13.64%
22.51
13.32%
25.32
12.50%
27.40
8.22%
23.71
13.49%
21.75
8.24%
24.79
13.96%
27.07
9.19%
stock based compensation to revenue
tangible asset value
9.41B
-
11.00B
16.94%
12.81B
16.48%
14.35B
11.99%
16.09B
12.14%
17.88B
11.10%
19.43B
8.65%
18.06B
7.05%
16.83B
6.82%
19.30B
14.67%
23.72B
22.91%
tangible book value per share
12.91
-
15.10
16.93%
17.59
16.47%
19.70
11.99%
22.09
12.14%
24.54
11.09%
26.65
8.63%
23.10
13.33%
21.18
8.33%
24.28
14.64%
27.34
12.63%
working capital
5.43B
-
6.17B
13.76%
6.03B
2.29%
6.44B
6.84%
6.90B
7.12%
9.22B
33.59%
9.10B
1.36%
6.38B
29.84%
5.78B
9.48%
8.00B
38.53%
11.50B
43.69%

All numbers in (except ratios and percentages)